Published in Immunology on October 01, 1972
Analysis of the stimulation-inhibition paradox exhibited by lymphocytes exposed to concanavalin A. J Exp Med (1976) 1.51
Activation and proliferation signals in mouse B cells. IV. Concanavalin A stimulates B cells to leave G0, but not to proliferate. Immunology (1984) 1.03
Mitogenic properties of lectin and its chemical dervatives. Proc Natl Acad Sci U S A (1973) 0.99
Suppression of in vitro lymphocyte DNA synthesis by killed Pseudomonas aeruginosa. Infect Immun (1983) 0.95
Subpopulations of mouse spleen lymphocytes. I. Dissociation between the reactivities to different "non-specific" mitogens. Immunology (1974) 0.92
An unusual response of hamster lymphocytes to PHA. Immunology (1973) 0.91
Lymphocyte response to T-cell mitogen during experimental gingivitis in humans. Infect Immun (1976) 0.81
Antigen-induced proliferative response to murine thymus cells in vitro. Infect Immun (1974) 0.75
Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol (1971) 6.43
The mechanism of immunological paralysis. Adv Immunol (1968) 5.53
Infectious immunological tolerance. Immunology (1971) 5.30
The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol (1970) 4.62
Evidence for a small pool of immunocompetent cells in the mouse thymus. Exp Cell Res (1969) 3.17
Active suppression of immunoglobulin allotype synthesis. I. Chronic suppression after perinatal exposure to maternal antibody to paternal allotype in (SJL x BALB-c)F 1 mice. J Exp Med (1972) 3.02
THYMECTOMY: PROLONGATION OF IMMUNOLOGICAL TOLERANCE IN THE ADULT MOUSE. Science (1963) 2.06
AN EFFECT OF THYMECTOMY ON RECOVERY FROM IMMUNOLOGICAL PARALYSIS. Immunology (1964) 1.87
Cellular events in the induction and loss of tolerance to pneumococcal polysaccharides. Transplant Rev (1972) 1.85
Recovery from immunological paralysis in relation to age and residual antigen. Immunology (1965) 1.58
The abrogation of sheep erythrocyte tolerance in rats by means of the transfer of allogeneic lymphocytes. J Exp Med (1970) 1.43
Rapid breaking of tolerance against Escherichia coli lipopolysaccharide in vivo and in vitro. J Exp Med (1972) 1.40
Autosensitization in vitro. J Exp Med (1971) 1.33
Immunocyte triggering. Cell Immunol (1970) 1.24
Induction and reversal of immune paralysis in vitro. J Exp Med (1970) 1.16
Differential effect of medium change in lymphocyte cultures stimulated by PPD tuberculin or PHA. Cell Immunol (1972) 0.80
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
Regulatory effect of antibody on the immune response. Adv Immunol (1968) 6.03
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity (1996) 4.02
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27
Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte. Cell (1977) 3.23
Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev (1991) 3.08
T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci U S A (1980) 3.08
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun (1993) 2.83
Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages. J Exp Med (1977) 2.68
Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur J Immunol (1979) 2.59
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet (1995) 2.43
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Frequency of antigen-sensitive cells to thymus-independent antigens. Cell Immunol (1971) 2.39
Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol (1998) 2.38
A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scand J Immunol (1979) 2.35
Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Eur J Immunol (1974) 2.33
Long term growth in vitro of human T cell blasts with maintenance of specificity and function. J Immunol (1979) 2.25
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
Synthesis, surface deposition and secretion of immunoglobulin M in bone marrow-derived lymphocytes before and after mitogenic stimulation. Transplant Rev (1973) 2.14
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood (2001) 2.13
19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro. Nature (1965) 2.12
Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors. Eur J Immunol (1979) 2.10
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol (1969) 2.03
High mobility group 1 B-box mediates activation of human endothelium. J Intern Med (2003) 2.00
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol (1972) 1.93
Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93
Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun (1995) 1.88
Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87
Persistence of immunogenicity of two complex antigens retained in vivo. Immunology (1968) 1.87
A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J Exp Med (1996) 1.86
Antigen-specific T-helper cells stimulate H-2-compatible and H-2-incompatible B-cell blasts polyclonally. J Exp Med (1980) 1.85
Ribavirin treatment for chronic hepatitis C. Lancet (1991) 1.84
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
The kinectics of proliferation and maturation of mitogen-activated bone marrow-derived lymphocytes. Eur J Immunol (1974) 1.81
Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol (1998) 1.80
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol (2001) 1.80
Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem (1984) 1.77
H-2-unrestricted polyclonal maturation without replication of small B cells induced by antigen-activated T cell help factors. Eur J Immunol (1980) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age. Allergy (2000) 1.75
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
IgM in bone marrow-derived lymphocytes. Synthesis, surface deposition, turnover and carbohydrate composition in unstimulated mouse B cells. Eur J Immunol (1974) 1.71
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1995) 1.71
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol (1970) 1.71
Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST). Br J Cancer (2007) 1.68
T cell growth factor abrogates concanavalin A-induced suppressor cell function. J Exp Med (1981) 1.68
Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis (1995) 1.64
Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A (1987) 1.63
RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol (2001) 1.63
In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62
Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature (1981) 1.61
IgM-producing tumors in the BALB-c mouse: a model for B-cell maturation. J Exp Med (1974) 1.61
Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity (1999) 1.61
Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators. Scand J Immunol (1974) 1.57
Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) (1998) 1.56
The effector cell in antibody-induced cell mediated immunity. Transplant Rev (1973) 1.56
Cloning of murine transformed cell lines in suspension culture with efficiencies near 100%. Exp Cell Res (1978) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
An Arabidopsis thaliana protein homologous to cyanobacterial high-light-inducible proteins. Plant Mol Biol (2000) 1.54
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
The switch from IgM to IgG secretion in single mitogen-stimulated B-cell clones. J Exp Med (1978) 1.52
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol (1972) 1.51
Immunological unresponsiveness to thymus-independent antigens: two fundamentally different genetic mechanisms of B-cell unresponsiveness to dextran. J Exp Med (1977) 1.50
A glycyl radical site in the crystal structure of a class III ribonucleotide reductase. Science (1999) 1.49
Plants lacking the main light-harvesting complex retain photosystem II macro-organization. Nature (2003) 1.48
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. Cell Immunol (1972) 1.48